当前位置: X-MOL 学术J. Child Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evaluation of Febrile Seizure Diagnoses Associated With COVID-19
Journal of Child Neurology ( IF 1.9 ) Pub Date : 2022-03-14 , DOI: 10.1177/08830738221086863
Katsiah Cadet 1 , Jessica Boegner 2 , Gary D Ceneviva 3 , Neal J Thomas 3, 4 , Conrad Krawiec 3
Affiliation  

Background/ObjectivesInfections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be associated with febrile seizures, but the overall frequency and outcomes are unknown. The objectives of this study are to (1) determine the frequency of pediatric subjects diagnosed with febrile seizures and COVID-19, (2) evaluate patient characteristics, and (3) describe the treatments (medications and need for invasive mechanical ventilation) applied.MethodsThis was a retrospective study utilizing TriNetX electronic health record data. We included subjects ranging from 0 to 5 years of age with a diagnosis of febrile seizures (R56.00, R56.01) and COVID-19 (U07.1). We extracted the following data: age, race, ethnicity, diagnostic codes, medications, laboratory results, and procedures.ResultsDuring this study period, 8854 pediatric subjects aged 0-5 years were diagnosed with COVID-19 among 34 health care organizations and 44 (0.5%) were also diagnosed with febrile seizures (simple, 30 [68.2%]; complex, 14 [31.8%]). The median age was 1.5 years (1, 2), there were no reported epilepsy diagnoses, and a proportion required hospitalization (11; 25.0%) and critical care services (4; 9.1%).ConclusionsCOVID-19 infections in children can be associated with febrile seizures. In our study, 0.5% of COVID-19 subjects were diagnosed with febrile seizures and approximately 9% of subjects were reported to require critical care services. Febrile seizures, although serious, are not a commonly diagnosed neurologic manifestation of COVID-19.

中文翻译:

评估与 COVID-19 相关的热性惊厥诊断

背景/目标感染严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 可能与热性惊厥有关,但总体频率和结果尚不清楚。本研究的目的是 (1) 确定诊断为高热惊厥和 COVID-19 的儿科受试者的频率,(2) 评估患者特征,以及 (3) 描述所应用的治疗方法(药物和有创机械通气的需求)。方法这是一项利用 TriNetX 电子健康记录数据的回顾性研究。我们纳入了诊断为热性惊厥(R56.00、R56.01)和 COVID-19(U07.1)的 0 至 5 岁的受试者。我们提取了以下数据:年龄、种族、民族、诊断代码、药物、实验室结果和程序。结果在这个研究期间,在 34 个卫生保健机构中,8854 名 0-5 岁的儿科受试者被诊断出患有 COVID-19,44 名(0.5%)也被诊断出患有高热惊厥(简单,30 [68.2%];复杂,14 [31.8%])。中位年龄为 1.5 岁 (1, 2),没有报告癫痫诊断,需要住院治疗 (11; 25.0%) 和重症监护服务 (4; 9.1%) 的比例。 结论 儿童 COVID-19 感染可能与伴有高热惊厥。在我们的研究中,0.5% 的 COVID-19 受试者被诊断出患有高热惊厥,据报道约有 9% 的受试者需要重症监护服务。热性惊厥虽然很严重,但并不是 COVID-19 的常见神经系统表现。30 [68.2%];复杂,14 [31.8%])。中位年龄为 1.5 岁 (1, 2),没有报告癫痫诊断,需要住院治疗 (11; 25.0%) 和重症监护服务 (4; 9.1%) 的比例。 结论 儿童 COVID-19 感染可能与伴有高热惊厥。在我们的研究中,0.5% 的 COVID-19 受试者被诊断出患有高热惊厥,据报道约有 9% 的受试者需要重症监护服务。热性惊厥虽然很严重,但并不是 COVID-19 的常见神经系统表现。30 [68.2%];复杂,14 [31.8%])。中位年龄为 1.5 岁 (1, 2),没有报告癫痫诊断,需要住院治疗 (11; 25.0%) 和重症监护服务 (4; 9.1%) 的比例。 结论 儿童 COVID-19 感染可能与伴有高热惊厥。在我们的研究中,0.5% 的 COVID-19 受试者被诊断出患有高热惊厥,据报道约有 9% 的受试者需要重症监护服务。热性惊厥虽然很严重,但并不是 COVID-19 的常见神经系统表现。5% 的 COVID-19 受试者被诊断出患有高热惊厥,据报道约有 9% 的受试者需要重症监护服务。热性惊厥虽然很严重,但并不是 COVID-19 的常见神经系统表现。5% 的 COVID-19 受试者被诊断出患有高热惊厥,据报道约有 9% 的受试者需要重症监护服务。热性惊厥虽然很严重,但并不是 COVID-19 的常见神经系统表现。
更新日期:2022-03-14
down
wechat
bug